Acute chest syndromeMANAGEMENT

HEMATOLOGIC AND ONCOLOGIC PRESENTATIONS · 12 SECTIONS

⚲

537 items

☷ Legend

⚲

Cardiovascular Presentations66▾

Respiratory Presentations47▾

Neurological Presentations77▾

Gastrointestinal Presentations63▾

Genitourinary and Reproductive Presentations44▾

Infectious Disease Presentations146▾

Trauma Presentations88▾

Toxicologic Presentations67▾

Psychiatric Presentations25▾

Musculoskeletal and Rheumatologic Presentations89▾

Dermatology Presentations21▾

Environmental and Exposure Presentations26▾

Hematologic and Oncologic Presentations30▾

Acute chest syndrome Acute Hemolytic Transfusion Reaction Aplastic Anemia (Crisis)Autoimmune Hemolytic Anemia Coagulopathy Delayed Hemolytic Transfusion Reaction Disseminated Intravascular Coagulation (DIC)Essential Thrombocythemia Febrile Non-hemolytic Transfusion Reaction Graft Versus Host Disease (Acute)Hemolytic Uremic Syndrome (HUS)Hemophilia A (Bleeding Crisis)Heparin-Induced Thrombocytopenia (HIT)Hyperviscosity syndrome Immune Thrombocytopenic Purpura (ITP)Leukemoid Reaction Myelofibrosis Paroxysmal Nocturnal Hemoglobinuria Polycythemia Vera (Crisis)Pure Red Cell Aplasia Sickle Cell (Acute Chest Syndrome)Sickle Cell (Splenic Sequestration)Sickle cell crisis (vaso-occlusive)Symptomatic anemia Thrombocytopenia (severe)Thrombotic Thrombocytopenic Purpura (TTP)Transfusion-Associated Circulatory Overload (TACO)Transfusion-Related Acute Lung Injury (TRALI)Tumor lysis syndrome Von Willebrand Disease (Bleeding)

Pediatric-Specific Presentations13▾

Endocrine and Metabolic Presentations42▾

ENT and Maxillofacial Presentations21▾

Ophthalmologic Presentations15▾

Obstetric Presentations17▾

Systemic and Miscellaneous Presentations15▾

01Approach to the Critical Patient/attcp60

Immediate priorities

›First-hour stabilization

›High-acuity triage for suspected acute chest syndrome in sickle cell disease

›Respiratory distress

›Hypoxemia relative to baseline

›Continuous pulse oximetry

›Target SpO2 92% or higher

›Higher target for pregnancy or chronic hypoxemia baseline individualized

›Supplemental oxygen

›Nasal cannula escalation to face mask as needed

›High-flow nasal cannula for persistent hypoxemia

›Early blood bank notification

›Type and screen

›Extended red cell phenotype matching plan

›Early hematology consultation

›Transfusion strategy planning

›Alloimmunization history review

›Early ICU team notification triggers

›Rapidly rising oxygen requirement

›Altered mental status

›Hemodynamic instability

›Respiratory failure escalation

›Noninvasive ventilation for increased work of breathing without contraindications

›Close monitoring for fatigue and worsening hypoxemia

›Intubation preparation

›Difficult airway risk assessment

›Post-intubation ventilator strategy for ARDS physiology

›Post-intubation hypotension risk mitigation

›Conservative induction dosing

›Vasopressor readiness

Hemodynamic and monitoring goals

›Monitoring bundle

›Frequent vital signs

›Respiratory rate trending

›Temperature trending

›Cardiac monitoring for hypoxemia and anemia stress

›QT-prolonging medication review

›Strict intake and output

›Avoid fluid overload

›Fluids strategy

›Euvolemia goal

›Isotonic maintenance only if poor oral intake

›Avoid aggressive boluses without shock physiology

›Shock pathway if present

›Sepsis protocol integration

›Point-of-care ultrasound for volume status

Key concepts

›Working definition

›New pulmonary infiltrate on imaging

›With fever or respiratory symptoms

›With chest pain or hypoxemia

›Acute decline can occur within hours

›Close reassessment cadence

›Early multimodal therapy

›Oxygenation support

›Prevent hypoxemia driven sickling

›Antibiotics for atypical and typical pathogens

›Early administration in febrile or infiltrate cases

›Lung expansion therapy

›Incentive spirometry to reduce atelectasis

›Transfusion for oxygen delivery and HbS reduction

›Simple transfusion for moderate disease

›Exchange transfusion for severe or progressive disease

02History/hx54

Symptom profile and timeline

›Presenting features

›Chest pain

›Pleuritic component

›Rib infarction suspicion

›Cough

›Productive versus dry

›Dyspnea

›Exertional limitation change

›Fever or chills

›Peak temperature and duration

›Wheeze

›Asthma exacerbation overlap

›Hemoptysis

›Pulmonary embolism consideration

›Timing

›Symptom onset time

›Rapid progression within 24 hours risk

›Recent vaso-occlusive pain episode

›Opioid use and hypoventilation risk

Sickle cell disease context

›Genotype and baseline

›HbSS

›HbSC

›HbS beta thalassemia

›Baseline hemoglobin g/L

›Baseline oxygen saturation

›Prior acute chest syndrome episodes

›Prior ICU admission

›Prior exchange transfusion

›Known triggers pattern

›Disease-modifying therapy

›Hydroxyurea use and adherence

›Recent transfusion program

›Voxelotor use

›Crizanlizumab use

Risk factors and exposures

›Infection exposures

›Household viral illness

›Recent influenza like illness

›Thromboembolism risk

›Prior VTE

›Recent immobilization

›Central venous catheter

›Pulmonary comorbidity

›Asthma diagnosis

›Obstructive sleep apnea

›Smoking or vaping exposure

›Recent procedures

›Surgery or anesthesia in last 2 weeks

›Recent bronchoscopy

Transfusion safety history

›Alloimmunization history

›Known antibodies list

›Prior delayed hemolytic transfusion reaction

›Prior transfusion complications

›Hyperhemolysis history

›Transfusion associated circulatory overload history

03Physical Exam/exam46

General and respiratory assessment

›Severity markers

›Work of breathing

›Accessory muscle use

›Inability to speak full sentences

›Mental status

›Somnolence from hypoxemia or opioids

›Perfusion

›Delayed capillary refill

›Respiratory exam

›Breath sounds

›Focal crackles

›Decreased air entry

›Wheeze

›Bronchospasm overlap

›Pleural rub

›Pleuritis consideration

Vital signs and oxygenation

›Oxygenation and ventilation

›SpO2 on room air and with oxygen

›Comparison to known baseline

›Respiratory rate trend

›Tachypnea progression

›Fever assessment

›Temperature peak

›Sepsis physiology evaluation

›Hemodynamics

›Hypotension

›Sepsis or massive PE consideration

›Tachycardia

›Pain versus hypoxemia versus anemia

Cardiovascular and volume status

›Cardiac exam

›New murmur

›High output state

›Signs of right heart strain

›Elevated JVP

›Volume status exam

›Peripheral edema

›Fluid overload risk

›Lung exam for overload pattern

›Diffuse crackles

PITFALLS

›Missed acute chest syndrome

›Normal initial chest radiograph

›Repeat imaging if clinical worsening

›Pain crisis with hypoventilation

›Atelectasis evolving to infiltrate

›Asthma misattribution

›Infiltrate and hypoxemia still treated as acute chest syndrome

04Differential Diagnosis/ddx34

Life-threatening pulmonary and cardiac causes

›High-risk alternatives

›Pulmonary embolism ICD-10 I26.99

›Pleuritic pain

›Unexplained tachycardia

›Severe community acquired pneumonia ICD-10 J18.9

›Lobar consolidation

›Sepsis physiology

›Acute respiratory distress syndrome ICD-10 J80

›Bilateral opacities

›Refractory hypoxemia

›Acute heart failure ICD-10 I50.9

›Volume overload signs

›Cardiomegaly

›Myocardial ischemia ICD-10 I21.9

›Ischemic ECG changes

›Troponin elevation

Mimics and overlapping sickle complications

›Sickle related considerations

›Atelectasis ICD-10 J98.11

›Hypoventilation

›Postoperative state

›Fat embolism syndrome

›Neurologic changes

›Petechiae

›Rib infarction

›Localized chest wall tenderness

›Hypoventilation due to pain

›Acute asthma exacerbation ICD-10 J45.901

›Wheeze predominant

›Prior asthma history

Coding aligned sickle chest entities

›Sickle cell disease with acute chest syndrome

›ICD-10 D57.01 HbSS disease with acute chest syndrome

›ICD-10 D57.211 HbSC disease with acute chest syndrome

›ICD-10 D57.411 Sickle beta plus thalassemia with acute chest syndrome

›ICD-10 D57.811 Other sickle cell disorders with acute chest syndrome

05Laboratory Tests/lt46

Core labs and trending

›Baseline severity and trend panel

›Complete blood count with differential

›Hemoglobin g/L trend from baseline

›Drop 10 g/L or more from baseline as higher risk marker

›Platelets trend

›Falling platelets as severe disease marker

›Reticulocyte count

›Bone marrow response adequacy

›Inappropriately low reticulocytes suggests aplasia or marrow suppression

›Electrolytes and creatinine mmol/L

›Renal function for antibiotic dosing

›Acute kidney injury impact on fluid strategy

›Hemolysis and hepatic panel

›Total bilirubin mmol/L

›Hemolysis baseline context

›AST

›Hepatic injury screen

›ALT

›Hepatic injury screen

Infection evaluation

›Microbiology bundle

›Blood cultures

›Before antibiotics when feasible without delay

›Low sensitivity but important for bacteremia detection

›Respiratory viral PCR panel

›Influenza

›Antiviral decision support

›SARS-CoV-2

›Isolation and treatment implications

›Sputum culture

›If productive cough and able to expectorate

›Limited yield but may guide de-escalation

›Inflammatory markers

›C reactive protein

›Trend support for infection or inflammation

›Procalcitonin

›Adjunct only

›Do not use alone to withhold antibiotics

Gas exchange assessment

›Oxygenation assessment tests

›Arterial blood gas

›PaO2 mmHg

›PaO2 under 60 mmHg as severe marker

›PaCO2 mmHg

›Rising PaCO2 as fatigue marker

›Venous blood gas

›If ABG not feasible and clinical stability

›PaO2 not interchangeable with ABG

06Diagnostic Tests/dt65

Scoring Systems

›Severity stratification framework

›No universally validated acute chest syndrome score

›Use physiologic severity features for escalation decisions

›High severity feature set

›Oxygen requirement rapidly increasing

›Escalation to ICU evaluation

›Multilobar infiltrates

›Exchange transfusion consideration

›PaO2 under 60 mmHg on room air

›Severe classification

›Need for noninvasive ventilation

›Severe classification

›Need for intubation

›Severe classification

›Hemodynamic instability

›Sepsis or massive PE evaluation

›Moderate severity feature set

›New infiltrate with mild hypoxemia responsive to low-flow oxygen

›Simple transfusion consideration

›Fever with suspected pneumonia

›Antibiotics and admission

MRI

›MRI chest role

›Limited acute utility

›Longer acquisition time

›Motion sensitivity in tachypnea

›Indications

›Alternative diagnosis evaluation when CT contraindicated

›Mediastinal mass

›Research or subacute complications

›Pulmonary infarction characterization

›Contraindications

›Unstable respiratory status

›Non-MRI compatible implants

›CT chest pathways

›CT pulmonary angiography

›Suspected pulmonary embolism

›Pleuritic pain out of proportion

›Unexplained tachycardia

›D-dimer not reliable for exclusion in sickle cell disease

›Contrast risk mitigation

›Creatinine based risk assessment

›CT chest without angiography

›Complication evaluation

›Effusion

›Abscess

›Alternative diagnosis

›Interpretation pearls

›Atelectasis can coexist with infiltrate

›Treat as acute chest syndrome when clinical criteria met

Ultrasound

›Point-of-care ultrasound applications

›Lung ultrasound

›Consolidation

›Dynamic air bronchograms support pneumonia

›Pleural effusion

›Procedural planning support

›B-lines

›Pulmonary edema consideration in fluid overload

›Cardiac ultrasound

›Right ventricular strain

›Pulmonary embolism consideration

›LV function

›Cardiogenic contribution evaluation

›IVC ultrasound

›Volume status adjunct

›Avoid over-resuscitation with fluids

07Disposition/dispo26

Admission and level of care

›Default disposition

›Hospital admission for suspected acute chest syndrome

›Early deterioration risk

›Need for serial reassessment

›ICU or step-down criteria

›Escalating oxygen requirement

›High-flow nasal cannula need

›Noninvasive ventilation need

›PaO2 under 60 mmHg

›Severe classification

›Multilobar infiltrates

›High risk for respiratory failure

›Altered mental status

›Hypercapnia or hypoxemia concern

›Hemodynamic instability

›Sepsis pathway integration

›Transfer criteria

›No exchange transfusion capability onsite

›Severe or rapidly progressive disease

›Lack of ICU resources

›Need for ventilatory support

Discharge rare scenarios

›Discharge uncommon

›Consider only after inpatient observation course

›Stable on room air at baseline saturation

›Improving symptoms

›Reliable follow-up within 24 to 48 hours

08Treatment/t105

Core bundle

›Initial therapy bundle

›Oxygen support

›Titrate to SpO2 92% or higher

›Consider higher targets in pregnancy

›Antibiotics

›Ceftriaxone IV 1 g every 24 hours

›Severe illness dose 2 g every 24 hours

›Azithromycin IV or PO 500 mg day 1

›Then 250 mg daily days 2 to 5

›Penicillin allergy alternative

›Levofloxacin IV or PO 750 mg daily

›MRSA coverage when indicated

›Vancomycin IV 15 to 20 mg per kg

›Trough or AUC guided dosing per local protocol

›Lung expansion therapy

›Incentive spirometry 10 breaths every 2 hours while awake

›Early use reduces atelectasis risk

›Early ambulation as tolerated

›VTE prevention and ventilation support

›Analgesia and sedation safety

›Opioid based pain control with monitoring

›Avoid oversedation and hypoventilation

›Multimodal adjuncts

›Acetaminophen PO 650 to 1000 mg every 6 hours

›Maximum 4000 mg per day

›Ketorolac IV 15 mg every 6 hours

›Maximum 60 mg per day

›Avoid in renal dysfunction and bleeding risk

Bronchodilators and airway inflammation

›Bronchospasm management

›Albuterol inhaled 4 to 8 puffs every 20 minutes for 1 hour

›Then 2 to 4 puffs every 4 hours as needed

›Ipratropium inhaled 4 puffs every 20 minutes for 1 hour

›Then every 6 hours as needed

›Systemic corticosteroids

›Routine use avoided

›Rebound vaso-occlusive pain risk after discontinuation

›Selective use

›Severe asthma exacerbation overlap

›Prednisone PO 40 to 60 mg daily

›Short course with plan for taper and close follow-up

Transfusion strategy

›Simple transfusion

›Indications

›Hemoglobin drop 10 g/L or more from baseline with symptoms

›Hypoxemia not corrected with low-flow oxygen

›Progressive infiltrate without severe criteria

›Targets

›Post-transfusion hemoglobin around 100 g/L

›Avoid overtransfusion and hyperviscosity

›Product selection

›Leukoreduced packed red blood cells

›Febrile reaction reduction

›Extended phenotype matched units

›Rh and Kell matched at minimum when feasible

›Exchange transfusion

›Indications

›Rapid clinical deterioration

›Escalating oxygen requirement over hours

›Multilobar infiltrates

›Severe classification

›PaO2 under 60 mmHg on room air

›Severe classification

›Need for noninvasive ventilation

›Severe classification

›Need for intubation

›Severe classification

›Goals

›Hemoglobin S fraction reduction target under 30%

›Use local protocol and hematology guidance

›Hemoglobin target around 100 g/L

›Avoid hyperviscosity

›Logistics

›Automated erythrocytapheresis preferred when available

›Faster HbS reduction

›Transfusion complication mitigation

›Alloimmunization risk reduction

›Antibody history reconciliation before issuing blood

›Delayed hemolytic transfusion reaction vigilance

›New pain and falling hemoglobin after transfusion

Anticoagulation and VTE prevention

›VTE prophylaxis for admitted patients without contraindication

›Enoxaparin SC 40 mg daily

›Renal dosing adjustment per local protocol

›Unfractionated heparin SC 5000 units every 8 to 12 hours

›Alternative when renal dysfunction

›Therapeutic anticoagulation only with confirmed indication

›Confirmed pulmonary embolism

›DOAC selection or heparin based on clinical context

Adjuncts and escalation therapies

›Antibiotic escalation triggers

›Septic shock

›Broad spectrum coverage per local sepsis guideline

›Immunocompromised state

›Expanded coverage and infectious disease consultation

›Antiviral therapy

›Influenza suspected or confirmed

›Oseltamivir PO 75 mg twice daily for 5 days

›Initiate regardless of symptom duration when hospitalized

›Pleural effusion management

›Large effusion with respiratory compromise

›Diagnostic thoracentesis

›Therapeutic drainage with ultrasound guidance

›Ventilation strategy for ARDS physiology

›Lung protective ventilation

›Tidal volume 6 ml per kg predicted body weight

›Plateau pressure 30 cm H2O or lower

›Prone positioning for refractory hypoxemia

›ICU protocol based implementation

09Special Populations/sp33

Pregnancy

›Pregnancy considerations

›Maternal oxygenation priority

›Higher SpO2 target individualized

›Early ICU involvement for worsening hypoxemia

›Obstetrics consultation early

›Fetal monitoring plan

›Medication safety

›Avoid NSAIDs in later gestation when contraindicated

›Antibiotics selection compatible with pregnancy

›Transfusion thresholds lower for maternal fetal oxygen delivery

›Hematology and obstetrics joint decision

Geriatric

›Older adult considerations

›Higher cardiopulmonary comorbidity burden

›Lower tolerance for anemia and hypoxemia

›Fluid overload susceptibility

›Conservative IV fluid approach

›Renal dosing adjustments

›Antibiotics and anticoagulation

Pediatrics

›Pediatric acute chest syndrome

›Higher viral trigger prevalence

›Viral PCR utility

›Weight-based antibiotic dosing

›Ceftriaxone IV 50 mg per kg every 24 hours

›Maximum 2 g daily

›Azithromycin IV or PO 10 mg per kg day 1

›Maximum 500 mg

›Then 5 mg per kg daily days 2 to 5

›Maximum 250 mg

›Transfusion dosing

›Packed red blood cells 10 ml per kg

›Target hemoglobin around 100 g/L

›Incentive spirometry adaptation

›Bubble blowing or age-appropriate lung expansion play

10Background/b32

Epidemiology

›Epidemiologic overview

›Common cause of hospitalization and mortality in sickle cell disease

›Occurs in both children and adults

›Peak occurrence patterns

›Children higher frequency

›Adults higher severity and ICU need

›Recurrence risk

›Prior acute chest syndrome increases future risk

Pathophysiology

›Mechanisms

›Pulmonary vaso-occlusion from sickling

›Hypoxemia amplifies sickling cascade

›Infection triggers

›Viral and atypical bacterial pathogens common

›Atelectasis and hypoventilation

›Pain and opioid effect

›Reduced lung expansion

›Fat embolism from bone marrow necrosis

›Sudden hypoxemia and neurologic features

›Ventilation perfusion mismatch

›Shunt physiology with infiltrates

Therapeutic Considerations

›Rationale for key interventions

›Oxygen therapy

›Reduces hypoxemia driven sickling

›Antibiotics

›Infection common and difficult to exclude early

›Incentive spirometry

›Reduces atelectasis progression

›Transfusion

›Improves oxygen carrying capacity

›Reduces HbS fraction when exchange performed

›Avoidance of overhydration

›Pulmonary edema risk in compromised lungs

11Patient Discharge Instructions/pdi20

copy discharge instructions

›Discharge after acute chest syndrome hospitalization

›Medications

›Complete prescribed antibiotic course

›Continue home sickle therapies as directed

›Breathing exercises

›Incentive spirometry use several times daily for 3 to 5 days

›Hydration and activity

›Regular oral fluids

›Gentle ambulation daily

›Return immediately for

›Worsening shortness of breath

›Chest pain worsening

›Fever 38.0 C or higher

›New wheeze not relieved by inhaler

›Fainting or severe weakness

›Blue lips or fingers

›Follow-up

›Hematology visit within 1 week

›Primary care visit within 1 to 2 weeks

›Repeat chest imaging only if symptoms persist or recur

12References/r16

Clinical guidelines and key sources

›Guideline sources

›American Society of Hematology guidelines on sickle cell disease acute complications

›Acute chest syndrome management recommendations

›NHLBI evidence-based management of sickle cell disease expert panel report

›Acute chest syndrome and pain management sections

›British Society for Haematology sickle cell disease guidelines

›Transfusion and acute chest syndrome guidance

›Infectious Diseases Society of America community acquired pneumonia guidance

›Empiric antibiotic framework for hospitalized pneumonia

Evidence summaries and consensus

›Evidence notes

›Simple transfusion improves oxygen delivery and may halt progression in moderate disease

›Hyperviscosity risk when hemoglobin rises excessively

›Exchange transfusion reduces HbS fraction rapidly in severe disease

›Preferred when respiratory failure imminent

›Systemic corticosteroids associated with rebound pain episodes in some studies

›Avoid routine use without asthma indication

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.